Califf Expected To Ace Senate Panel Vote, As He Ups Emphasis On Safety Surveillance
This article was originally published in The Gray Sheet
The Senate Health, Education, Labor and Pensions Committee plans a confirmation vote on Robert Califf Jan. 12 to become the next FDA commissioner. Public health researchers and Sens. Sanders and Warren have argued that the long-time academic research leader's ties to industry are too close. Meanwhile, Califf recently has emphasized his focus on strengthening postmarket safety oversight.